Document Classification

Section Type: RESULTS

Text: Clopidogrel-exposed patients had a longer median duration of hospitalization (12. 0 days vs. 8. 9 days, p < 0. 0001), but fewer adverse composite ischemic events (death, myocardial infarction, or unplanned revascularization) at 30 days ; 12. 7 % vs. 17. 3 %, p = 0. 01), with nonsignificantly different rates of non-CABG-related major bleeding (3. 4 % vs. 3. 2 %, p = 0. 87) and post-CABG major bleeding (50. 3 % vs. 50. 9 %, p = 0. 83) compared with those patients not administered clopidogrel.